Healthcare provider profile · identity verified

Adam W Burrell, MD

Family Practice · FRANKLIN, NC · NPI 1952361495

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	393	115
Amlodipine Besylate	Amlodipine Besylate	340	95
Levothyroxine Sodium	Levothyroxine Sodium	333	85
Hydrochlorothiazide	Hydrochlorothiazide	288	77
Lisinopril	Lisinopril	244	73
Metoprolol Succinate	Metoprolol Succinate	182	50
Losartan Potassium	Losartan Potassium	170	46
Tamsulosin Hcl	Tamsulosin Hcl	150	44
Omeprazole	Omeprazole	149	45
Metformin Hcl	Metformin Hcl	127	38
Albuterol Sulfate Hfa	Albuterol Sulfate	125	34
Eliquis	Apixaban	102	23
Potassium Chloride	Potassium Chloride	98	25
Esomeprazole Magnesium	Esomeprazole Magnesium	96	30
Metoprolol Tartrate	Metoprolol Tartrate	95	28
Gabapentin	Gabapentin	85	28
Finasteride	Finasteride	77	20
Fluticasone Propionate	Fluticasone Propionate	77	23
Pantoprazole Sodium	Pantoprazole Sodium	74	19
Allopurinol	Allopurinol	72	23
Jardiance	Empagliflozin	69	17
Spironolactone	Spironolactone	68	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	68	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	17
Rosuvastatin Calcium	Rosuvastatin Calcium	63	17
Glipizide Er	Glipizide	50	16
Furosemide	Furosemide	49	18
Clopidogrel	Clopidogrel Bisulfate	45	12
Prednisone	Prednisone	44	31
Tramadol Hcl	Tramadol Hcl	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Colchicine	Colchicine	43	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	30
Famotidine	Famotidine	41	14
Paroxetine Hcl	Paroxetine Hcl	41	15
Simvastatin	Simvastatin	41	14
Montelukast Sodium	Montelukast Sodium	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	14
Ozempic	Semaglutide	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Trazodone Hcl	Trazodone Hcl	37	15
Valacyclovir	Valacyclovir Hcl	35	18
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Nitroglycerin	Nitroglycerin	32	12
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Meloxicam	Meloxicam	29	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Azelastine Hcl	Azelastine Hcl	26	11
Carvedilol	Carvedilol	26	suppressed
Methenamine Hippurate	Methenamine Hippurate	25	suppressed
Sertraline Hcl	Sertraline Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fluconazole	Fluconazole	18	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Atenolol	Atenolol	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Synthroid	Levothyroxine Sodium	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Ramipril	Ramipril	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Azithromycin	Azithromycin	12	12
Estradiol	Estradiol	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Nystatin	Nystatin	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error